Clinical Trial Update: Evaluate the Efficacy and Safety of Polyene Phosphatidylcholine Injection (AYP-101) for the Reduction of Submental Fat [Phase 2]

View source ↗

Summary

Phase 2 trial completed evaluating the efficacy and safety of Polyene Phosphatidylcholine Injection (AYP-101) for reducing submental fat.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Submental Fullness

Drugs mentioned

• Polyene phosphatidylcholine injection (polyene phosphatidylcholine)

Snippet

Sponsor: AMIpharm Co., Ltd. | Conditions: Moderate or Severe Submental Fullness | Phase 2 | Status: COMPLETED